Cargando…

CRISPR/Cas9-induced structural variations expand in T lymphocytes in vivo

CRISPR/Cas9 has been adapted to disrupt endogenous genes in adoptive T-lymphocyte therapy to prevent graft-versus-host disease. However, genome editing also generates prevalent deleterious structural variations (SVs), including chromosomal translocations and large deletions, raising safety concerns...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Jinchun, Zou, Ziye, Liu, Yang, Liu, Xuhao, Zhangding, Zhengrong, Xu, Mo, Hu, Jiazhi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Molecular Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9638931/ https://www.ncbi.nlm.nih.gov/pubmed/36243978 http://dx.doi.org/10.1093/nar/gkac887

Ejemplares similares

The impact of nucleosome structure on CRISPR/Cas9 fidelity
por: Handelmann, Christopher R, et al.
Publicado: (2023)

Development of a CRISPR/Cas9 System for Methylococcus capsulatus In Vivo Gene Editing
por: Tapscott, Timothy, et al.
Publicado: (2019)

Anti-CRISPR AcrIF9 functions by inducing the CRISPR–Cas complex to bind DNA non-specifically
por: Lu, Wang-Ting, et al.
Publicado: (2021)

Selective disruption of an oncogenic mutant allele by CRISPR/Cas9 induces efficient tumor regression
por: Koo, Taeyoung, et al.
Publicado: (2017)

Optimized CRISPR/Cas9 system for gene knockout in chicken DF1 cells
por: Zou, Kexin, et al.
Publicado: (2023)

Allele-specific genome editing using CRISPR–Cas9 is associated with loss of heterozygosity in diploid yeast
por: Gorter de Vries, Arthur R, et al.
Publicado: (2019)

Substrate Generation for Endonucleases of CRISPR/Cas Systems
por: Zoephel, Judith, et al.
Publicado: (2012)

A CRISPR Cas9 high-throughput genome editing toolkit for kinetoplastids
por: Beneke, Tom, et al.
Publicado: (2017)

Cas4–Cas1 fusions drive efficient PAM selection and control CRISPR adaptation
por: Almendros, Cristóbal, et al.
Publicado: (2019)

Nucleosomes inhibit target cleavage by CRISPR-Cas9 in vivo
por: Yarrington, Robert M., et al.
Publicado: (2018)

AAV-CRISPR/Cas9–Mediated Depletion of VEGFR2 Blocks Angiogenesis In Vitro
por: Wu, Wenyi, et al.
Publicado: (2017)

CRISPR/Cas9-mediated deletion of the Wiskott-Aldrich syndrome locus causes actin cytoskeleton disorganization in murine erythroleukemia cells
por: Fernández-Calleja, Vanessa, et al.
Publicado: (2019)

CRISPR repeat sequences and relative spacing specify DNA integration by Pyrococcus furiosus Cas1 and Cas2
por: Grainy, Julie, et al.
Publicado: (2019)

Highly efficient genome editing via CRISPR–Cas9 in human pluripotent stem cells is achieved by transient BCL-XL overexpression
por: Li, Xiao-Lan, et al.
Publicado: (2018)

Enhanced specificity mutations perturb allosteric signaling in CRISPR-Cas9
por: Nierzwicki, Lukasz, et al.
Publicado: (2021)

The Streptococcus thermophilus CRISPR/Cas system provides immunity in Escherichia coli
por: Sapranauskas, Rimantas, et al.
Publicado: (2011)

Improving CRISPR–Cas specificity with chemical modifications in single-guide RNAs
por: Ryan, Daniel E, et al.
Publicado: (2018)

The Cas6e ribonuclease is not required for interference and adaptation by the E. coli type I-E CRISPR-Cas system
por: Semenova, Ekaterina, et al.
Publicado: (2015)

Unique properties of spacer acquisition by the type III-A CRISPR-Cas system
por: Zhang, Xinfu, et al.
Publicado: (2021)

Hydrazone chemistry-mediated CRISPR/Cas12a system for bacterial analysis
por: Sheng, Anzhi, et al.
Publicado: (2022)

Coupling transcriptional activation of CRISPR–Cas system and DNA repair genes by Csa3a in Sulfolobus islandicus
por: Liu, Tao, et al.
Publicado: (2017)

A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells
por: Rivera-Torres, Natalia, et al.
Publicado: (2017)

CRISPR DNA elements controlling site-specific spacer integration and proper repeat length by a Type II CRISPR–Cas system
por: Kim, Jenny G, et al.
Publicado: (2019)

Detection and characterization of spacer integration intermediates in type I-E CRISPR–Cas system
por: Arslan, Zihni, et al.
Publicado: (2014)

Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system
por: Bikard, David, et al.
Publicado: (2013)

Type IV CRISPR–Cas systems are highly diverse and involved in competition between plasmids
por: Pinilla-Redondo, Rafael, et al.
Publicado: (2020)

Target RNA-guided protease activity in type III-E CRISPR–Cas system
por: Wang, Xiaoshen, et al.
Publicado: (2022)

An archaeal virus-encoded anti-CRISPR protein inhibits type III-B immunity by inhibiting Cas RNP complex turnover
por: Liu, Jilin, et al.
Publicado: (2023)

Dataset on nicotine-free, nontransgenic tobacco (Nicotiana tabacuml.) edited by CRISPR-Cas9
por: Schachtsiek, Julia, et al.
Publicado: (2019)

Spacer-length DNA intermediates are associated with Cas1 in cells undergoing primed CRISPR adaptation
por: Musharova, Olga, et al.
Publicado: (2017)

The action of Escherichia coli CRISPR–Cas system on lytic bacteriophages with different lifestyles and development strategies
por: Strotskaya, Alexandra, et al.
Publicado: (2017)

Spacer acquisition by Type III CRISPR–Cas system during bacteriophage infection of Thermus thermophilus
por: Artamonova, Daria, et al.
Publicado: (2020)

Consequences of Cas9 cleavage in the chromosome of Escherichia coli
por: Cui, Lun, et al.
Publicado: (2016)

Expanding application of CRISPR-Cas9 system in microorganisms
por: Zhao, Jing, et al.
Publicado: (2020)

DNA targeting by the type I-G and type I-A CRISPR–Cas systems of Pyrococcus furiosus
por: Elmore, Joshua, et al.
Publicado: (2015)

Different genome stability proteins underpin primed and naïve adaptation in E. coli CRISPR-Cas immunity
por: Ivančić-Baće, Ivana, et al.
Publicado: (2015)

Foreign DNA acquisition by the I-F CRISPR–Cas system requires all components of the interference machinery
por: Vorontsova, Daria, et al.
Publicado: (2015)

Two CRISPR/Cas9-mediated methods for targeting complex insertions, deletions, or replacements in mouse
por: Pineault, Kyriel M., et al.
Publicado: (2019)

Production of a Cloned Offspring and CRISPR/Cas9 Genome Editing of Embryonic Fibroblasts in Cattle
por: Singina, G. N., et al.
Publicado: (2021)

CRISPR/Cas9 in Gastrointestinal Malignancies
por: Jefremow, André, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4rt2a4mascs58co787tcjehl5s